Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: Differential long-term effects of intermittent and chronic morphine administration

Neuroscience

Volumn 76, Issue 1, 1996, Pages 167-176

  Tjon, G H K ^a   Voorn, P ^a   Vanderschuren, L J M J ^a   De Vries, T J ^a   Michiels, N H L M ^a   Jonker, A J ^a   Klop, H ^a   Nestby, P ^a   Mulder, A H ^a   Schoffelmeer, A N M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

caudate putamen; dynorphin; enkephalin; locomotor sensitization; neuroplasticity; nucleus accumbens

Indexed keywords

MORPHINE; PREPRODYNORPHIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030571615     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00363-6     Document Type: Article

References (47)

1. Acquas E., Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58:1992;1620-1625.
2. Angulo J. A., McEwen B. S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
3. Babbini M., Gaiardi M., Bartoletti M. Persistence of chronic morphine effects upon activity in rats 8 months after ceasing the treatment. Psychopharmacology. 22:1975;1193-1196.
4. αs and opioid peptide mRNA levels in discrete brain regions. J. Neurosci. Res. 36:1993;551-557.
5. Cole R. L., Konradi C., Douglass J., Hyman S. E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
6. Daunais J. B., McGinty J. F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
7. Fujiwara Y., Kazahaya Y., Nakashima M., Sato M., Otsuki S. Behavioral sensitization to metamphetamine in the rat: an ontogenic study. Psychopharmacology. 91:1987;316-319.
8. Heidbreder C. A., Goldberg S. R., Shippenberg T. S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616:1993;335-338.
9. Heidbreder C. A., Shippenberg T. S. U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. NeuroReport. 5:1994;1797-1801.
10. Höllt V. (1993) Regulation of opioid peptide gene expression. In Handbook of Experimental Pharmacology (ed. Herz A.), Vol. 104/I, pp. 307-346. Springer, Berlin.
11. Hurd Y. L., Brown E. E., Finlay J. M., Fibiger H. C., Gerfen C. R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Molec. Brain Res. 13:1992;165-170.
12. Hurd Y. L., Herkenham M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse. 13:1993;357-369.
13. Kalivas P. W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
14. Kalivas P. W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J. Neurosci. 13:1993;276-284.
15. Kalivas P. W., Stewart J. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
16. King G. R., Kuhn C., Ellinwood E. H. Jr. Dopamine efflux during withdrawal from continuous or intermittent cocaine. Psychopharmacology. 111:1993;179-184.
17. Klitenick M. A., DeWitte P., Kalivas P. W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12:1992;2623-2632.
18. Konradi C., Cole R. L., Heckers S., Hyman S. E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14:1994;5623-5634.
19. McDougall S. A., Duke M. A., Bolanos C. A., Crawford C. A. Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists. Psychopharmacology. 116:1994;483-490.
20. Mocchetti I., Costa E. In vivo studies of the regulation of neuropeptide stores in structures of rat brain. Neuropeptides. 26:1987;855-862.
21. Nestler E. J. Molecular mechanisms of drug addiction. J. Neurosci. 12(7):1992;2439-2450.
22. Paulson P. E., Robinson T. E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 19:1995;56-65.
23. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
24. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
25. Pickel V. M., Chan J., Sesack S. R. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res. 602:1993;275-289.
26. Pierce T. L., Tiong G. K. L., Olley J. E. Morphine and methadone dependence in the rat: withdrawal and brain met-enkephalin levels. Pharmac. Biochem. Behav. 42:1992;91-96.
27. Robinson T. E., Becker J. B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
28. Robinson T. E., Berridge K. C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
29. Romualdi P., Lesa G., Ferri S. Chronic opiate agonists down-regulate prodynorphin gene expression in rat brain. Brain Res. 563:1991;132-136.
30. A receptors modulate dopamine release from rat striatal synaptosomes. J. Neurochem. 61:1993;1634-1639.
31. Ronken E., Mulder A. H., Schoffelmeer A. N. M. Chronic activation of mu- and kappa-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization. J. Pharmac. exp. Ther. 268:1994;595-599.
32. Schoffelmeer A. N. M., De Vries T. J., Hogenboom F., Mulder A. H. Mu and delta opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile towards endogenous opioid peptides different from that of presynaptic mu, delta, and kappa receptors. J. Pharmac. exp. Ther. 267:1993;205-210.
33. Shani J., Azov R., Weissman B. A. Enkephalin levels in rat brain after various regimens of morphine administration. Neurosci. Lett. 12:1979;319-322.
34. Spanagel R., Herz A., Shippenberg T. S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
35. Spanagel R., Shippenberg T. S. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neurosci. Lett. 153:1993;232-236.
36. Spangler R., Unterwald E. M., Kreek M. J. "Binge" cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Molec. Brain Res. 19:1993;323-327.
37. Steiner H., Gerfen C. R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
38. Tjon G. H. K., De Vries T. J., Nestby P., Wardeh G., Mulder A. H., Schoffelmeer A. N. M. Intermittent and chronic morphine treatment induce long-lasting changes in delta-opioid receptor regulated acetylcholine release in rat striatum and nucleus accumbens. Eur. J. Pharmac. 283:1995;169-176.
39. Tjon G. H. K., De Vries T. J., Ronken E., Hogenboom F., Wardeh G., Mulder A. H., Schoffelmeer A. N. M. Repeated and chronic morphine administration causes differential long-lasting changes in dopaminergic neurotransmission in rat striatum without changing its delta- and kappa-opioid receptor regulation. Eur. J. Pharmac. 252:1994;205-212.
40. Uhl G. R., Ryan J. P., Schwartz J. P. Morphine alters preproenkephalin gene expression. Brain Res. 459:1988;391-397.
41. Valadez A., Schenk S. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration. Pharmac. Biochem. Behav. 47:1994;203-205.
42. Voorn P., Docter G. J. A rostrocaudal gradient in the synthesis of enkephalin in nucleus accumbens. NeuroReport. 3:1992;161-164.
43. Voorn P., Docter G. J., Jongen-Rêlo A. L., Jonker A. J. Rostrocaudal subregional differences in the response of enkephalin, dynorphin and substance P synthesis in rat nucleus accumbens to dopamine depletion. Eur. J. Neurosci. 6:1994;486-496.
44. Wang J. Q., Daunais J. B., McGinty J. F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353.
45. Wang J. Q., McGinty J. F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
46. Widnell K. L., Russell D. S., Nestler E. J. Regulation of expression of cyclic AMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. natn. Acad. Sci. U.S.A. 91:1994;10947-10951.
47. Young W. S. (1990) In situ hybridization histochemistry. In Methods for the Study of Neuronal Microcircuits and Synaptic Interactions (eds Wouterlood F. L. and Van der Pool A.), pp. 481-512. Elsevier, Amsterdam.